China National Chemical won European Union antitrust approval for its $43 billion takeover of Swiss pesticide maker Syngenta, a day after the US gave its blessing, bringing China’s largest foreign acquisition closer to the finish line.
ChemChina’s offer to divest some pesticides and other agricultural products will remove “problematic overlaps” and allow the EU to clear the deal, the European Commission said in an emailed statement. EU Competition Commissioner Margrethe Vestager praised the companies for being “prepared to address our concerns” with the concessions, she said at a news conference, as she blocked another deal based on a proposed divestment that fell short.
The US required the companies to divest three types of pesticides as a condition for completing the deal. The companies expect to close the deal by the end of June. The transaction still needs approval from Chinese antitrust authorities.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkey Ends Meta Investigation Over Threads and Instagram
Dec 8, 2024 by
CPI
Supreme Court to Hear CCI Petition on Amazon, Flipkart Antitrust Cases
Dec 8, 2024 by
CPI
Senators Urge Antitrust Probe Into FanDuel and DraftKings
Dec 8, 2024 by
CPI
Novo Holdings Secures EU Approval for $16.5 Billion Catalent Acquisition
Dec 8, 2024 by
CPI
US Appeals Court Upholds TikTok Divestment Law, Paving Way for Potential Ban
Dec 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead